Nina Peterson, CANS
Nina Peterson is a Certified Aesthetic Nurse Specialist (CANS) specializing in facial contouring and non-surgical mini facelifts with PDO threads. With over nine years of experience gained in dermatology and plastic surgery practices, Nina also works as a medical blogger and consultant for aesthetic practices and licensed individuals, bringing her background in plastic surgery and dermatology to provide valuable insights.
author’s articles
Sculptra vs Juvederm – Comparing Treatments
Did you know that the global rejuvenation market may experience a remarkable surge, from a $15 billion value in 2016...
Read More
Sculptra Jowls – Stimulating Collagen Production
Did you know that the severity and likelihood of jowls stem from aging? This loss of volume and elasticity causes...
Read More
BOTOX® Advertising Guide for Medical Practitioners
If you’re a medical spa owner performing BOTOX® treatments, you may wonder how to market them. You might be thinking...
Read More
Sculptra For Nasolabial Folds – Lift and Smooth Skin
According to the World Health Organization, a significant demographic shift is underway globally. By the year 2050, it is projected...
Read More
Sculptra Cheekbones – Defined, Firm Cheekbones
Recent statistics from the American Society of Plastic Surgeons reveal that the average cost of cheek implants is $3,781. This...
Read More
Sculptra Injections For Buttocks – All About the Treatment
Did you know that from 1991 to 2021, 89.84% of research articles available in the Web of Science Core Collection...
Read More
Sculptra For Neck – Restore Lost Volume
According to the International Society of Aesthetic Plastic Surgery, 2019 witnessed a significant surge in neck lift procedures performed globally,...
Read More
Saxenda Side Effects – What Your Patients Should Now
Trenson et al. (2022) conducted a study on a specific group of patients who received liraglutide treatment and adhered to...
Read More
Saxenda or Wegovy – Comparing Weight Loss Treatments
A 2022 comprehensive meta-analysis on treatments for weight loss management provides compelling evidence that glucagon-like peptide-1 receptor agonists (GLP-1RAs) consistently...
Read More
Saxenda FDA Approval – Information For Practitioners
According to a clinical trial, 85% of participants who used Saxenda experienced weight loss throughout the 56-week study. This treatment...
Read More